ITMI913241A0 - PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC MAUROLOGICAL DISEASES - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC MAUROLOGICAL DISEASES

Info

Publication number
ITMI913241A0
ITMI913241A0 IT91MI3241A ITMI913241A ITMI913241A0 IT MI913241 A0 ITMI913241 A0 IT MI913241A0 IT 91MI3241 A IT91MI3241 A IT 91MI3241A IT MI913241 A ITMI913241 A IT MI913241A IT MI913241 A0 ITMI913241 A0 IT MI913241A0
Authority
IT
Italy
Prior art keywords
maurological
neuroprotection
degenerative
ischemic
diseases
Prior art date
Application number
IT91MI3241A
Other languages
Italian (it)
Inventor
Stefano Poli
Federico Mailland
Germano Coppi
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to ITMI913241A priority Critical patent/IT1252163B/en
Publication of ITMI913241A0 publication Critical patent/ITMI913241A0/en
Priority to ES09202439A priority patent/ES2109114B1/en
Priority to DE4240798A priority patent/DE4240798A1/en
Publication of ITMI913241A1 publication Critical patent/ITMI913241A1/en
Application granted granted Critical
Publication of IT1252163B publication Critical patent/IT1252163B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ITMI913241A 1991-12-03 1991-12-03 PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC-BASED NEUROLOGICAL DISEASES IT1252163B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI913241A IT1252163B (en) 1991-12-03 1991-12-03 PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC-BASED NEUROLOGICAL DISEASES
ES09202439A ES2109114B1 (en) 1991-12-03 1992-12-01 PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN NEUROLOGICAL DISEASES OF A DEGENERATIVE OR ISCHEMICAL BASIS.
DE4240798A DE4240798A1 (en) 1991-12-03 1992-12-01 Neuro-protective agents preventing nerve damage - contain ergot derivs. e.g. clavine lysergic acid amide or 8-alpha-amino:ergoline derivs.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913241A IT1252163B (en) 1991-12-03 1991-12-03 PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC-BASED NEUROLOGICAL DISEASES

Publications (3)

Publication Number Publication Date
ITMI913241A0 true ITMI913241A0 (en) 1991-12-03
ITMI913241A1 ITMI913241A1 (en) 1993-06-03
IT1252163B IT1252163B (en) 1995-06-05

Family

ID=11361248

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI913241A IT1252163B (en) 1991-12-03 1991-12-03 PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC-BASED NEUROLOGICAL DISEASES

Country Status (3)

Country Link
DE (1) DE4240798A1 (en)
ES (1) ES2109114B1 (en)
IT (1) IT1252163B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (en) * 1996-07-02 1998-01-08 Hexal Ag Plaster for transdermal application of pergolide
FR2786099B1 (en) 1998-11-24 2000-12-29 Aventis Laboratoire NEW THERAPEUTIC APPLICATION OF 1,6-DIMETHYL-8BETA- HYDROXYMETHYL-10ALPHA-METHOXYERGOLINE
FR2786101B1 (en) 1998-11-24 2002-07-05 Aventis Laboratoire USE OF NICERGOLIN IN THE TREATMENT OF SPASTICITY
FR2786100B1 (en) * 1998-11-24 2002-03-01 Aventis Laboratoire NEW THERAPEUTIC APPLICATION OF NICERGOLIN
FR2801793B1 (en) * 1999-12-01 2003-07-04 Aventis Pharma Sa COMBINATION OF ERGOLIN AND RILUZOLE AND ITS USE AS A MEDICINAL PRODUCT
US6297254B1 (en) 1999-12-01 2001-10-02 Aventis Pharma S. A. Method for the prevention or treatment of a motoneuron disease
DE10053397A1 (en) * 2000-10-20 2002-05-02 Schering Ag Use of a dopaminergic active ingredient for the treatment of dopaminerg treatable diseases
DE10226459A1 (en) * 2002-06-13 2004-01-08 Neurobiotec Gmbh Use of dopamine partial agonists to treat restless legs syndrome
PT2091537E (en) * 2006-11-23 2013-08-29 Sinoxa Pharma Gmbh Pharmaceutical compositions for the treatment of capillary arteriopathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200603B (en) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa PHARMACEUTICAL COMPOSITION WITH DOPAMINERGIC ACTIVITY

Also Published As

Publication number Publication date
ES2109114A1 (en) 1998-01-01
IT1252163B (en) 1995-06-05
ITMI913241A1 (en) 1993-06-03
ES2109114B1 (en) 1998-06-16
DE4240798A1 (en) 1993-06-09

Similar Documents

Publication Publication Date Title
EE03108B1 (en) Pharmaceutical composition
FI981777A (en) Pharmaceutical composition
IT1276723B1 (en) INSULIN ANALOGUE FORMULATIONS
DK0585252T3 (en) Pharmaceutical formulations
ITRM910696A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION.
FI944832A0 (en) Pharmaceutical composition
DE4291156T1 (en) Improved pharmaceutical compositions
FI955311A (en) Pharmaceutical composition base
NZ237191A (en) 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
FI981956A (en) 2- (4-hydroxypiperidino) -1-alkanol derivatives as antihypertensives
ITMI913241A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION IN DEGENERATIVE OR ISCHEMIC MAUROLOGICAL DISEASES
MX9203505A (en) N-ARIL-N- (4- (1-ALQUILHETEROCICLICO) -PIPERIDINIL) AMIDES AND PHARMACEUTICAL COMPOSITIONS AND METHODS USING SUCH COMPOUNDS.
MX9200622A (en) PHARMACEUTICAL COMPOSITION
ITMI932540A0 (en) PHARMACEUTICAL COMPOSITION
ITTO920303A0 (en) "ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION"
ATE208364T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A-OXO-BUTANIC ACIDS
IT1290797B1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS
LV10579A (en) Pharmaceutical composition
ITPD910141A1 (en) PROCESS PERFECTED FOR THE REALIZATION OF FOOTWEAR
NZ239187A (en) Substituted 2-(9-fluorenonyl)-carbapenem derivatives, pharmaceutical compositions, and intermediates
KR950703559A (en) Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION
DK0418990T3 (en) 13-bromo- and 13,14-dibromo-ergolines, their preparation and use in pharmaceuticals
FI920845A (en) PHARMACEUTICAL COMPOSITION INNEHAOLLANDE INTERLEUKIN-2
SE9101348D0 (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971223